AVD Narrows Q3 Loss Amidst Sales Dip, Transformation Costs Fall

TL;DR

**AVD is still losing money, but the Q3 numbers show some green shoots from cost-cutting and transformation efforts, making it a speculative buy for turnaround plays.**

AI Summary

AMERICAN VANGUARD CORP (AVD) reported a net loss of $12.358 million for the three months ended September 30, 2025, a significant improvement from the $25.742 million net loss in the same period of 2024. For the nine months ended September 30, 2025, the net loss was $21.669 million, compared to $35.911 million in 2024. Net sales saw a slight increase of 0.85% to $119.313 million for the three months ended September 30, 2025, from $118.307 million in 2024, driven by a 21.9% increase in U.S. crop sales to $43.310 million. However, nine-month net sales decreased by 4.5% to $364.426 million from $381.659 million in 2024. Gross profit for the quarter more than doubled to $34.214 million from $17.293 million year-over-year, largely due to a substantial reduction in cost of sales by 15.75%. The company incurred $7.029 million in product liability claims during the quarter, which was not present in the prior year. Transformation expenses decreased significantly to $1.442 million for the quarter, down from $8.139 million in 2024, reflecting progress in its digital and structural transformation project. Long-term debt increased to $182.250 million as of September 30, 2025, from $147.332 million at December 31, 2024, indicating increased leverage.

Why It Matters

AVD's reduced net loss and improved gross profit margin for the quarter, despite a slight overall sales decline for the nine-month period, signal potential operational efficiencies from its ongoing transformation. For investors, the significant increase in long-term debt to $182.250 million warrants close attention, as it could impact future financial flexibility and shareholder returns. The competitive landscape in the agricultural chemicals sector remains intense, and AVD's ability to leverage its transformation to enhance product offerings and market share will be crucial. Employees might see continued restructuring as transformation efforts progress, while customers could benefit from standardized systems and improved product delivery.

Risk Assessment

Risk Level: medium — The company reported a net loss of $12.358 million for the quarter and $21.669 million for the nine months ended September 30, 2025, indicating continued unprofitability. Long-term debt increased by 23.7% to $182.250 million from $147.332 million at December 31, 2024, raising concerns about financial leverage and interest expense, which was $4.920 million for the quarter.

Analyst Insight

Investors should monitor AVD's progress on its transformation initiatives and their impact on sustained profitability. Evaluate the company's ability to manage its increasing debt load and its strategy for driving revenue growth, especially in international markets where sales declined by 5.9% for the nine months ended September 30, 2025.

Financial Highlights

revenue

$119.313M

total Debt

$182.250M

net Income

-$12.358M

eps

-$0.43

gross Margin

28.68%

revenue Growth

+0.85%

Revenue Breakdown

Key Numbers

• $12.358M — Net Loss (Q3 2025) (Improved from $25.742M in Q3 2024)
• $119.313M — Net Sales (Q3 2025) (Slight increase from $118.307M in Q3 2024)
• $34.214M — Gross Profit (Q3 2025) (More than doubled from $17.293M in Q3 2024)
• $85.099M — Cost of Sales (Q3 2025) (Decreased by 15.75% from $101.014M in Q3 2024)
• $7.029M — Product Liability Claims (Q3 2025) (New expense compared to $0 in Q3 2024)
• $1.442M — Transformation Expenses (Q3 2025) (Significantly down from $8.139M in Q3 2024)
• $182.250M — Long-term Debt (Sep 30, 2025) (Increased from $147.332M at Dec 31, 2024)
• $43.310M — U.S. Crop Sales (Q3 2025) (Increased by 21.9% from $35.533M in Q3 2024)
• $56.770M — International Sales (Q3 2025) (Decreased from $60.320M in Q3 2024)
• $0.43 — Net Loss Per Share (Q3 2025) (Improved from $0.91 in Q3 2024)

Key Players & Entities

• AMERICAN VANGUARD CORP (company) — registrant
• $12.358 million (dollar_amount) — net loss for Q3 2025
• $25.742 million (dollar_amount) — net loss for Q3 2024
• $119.313 million (dollar_amount) — net sales for Q3 2025
• $118.307 million (dollar_amount) — net sales for Q3 2024
• $34.214 million (dollar_amount) — gross profit for Q3 2025
• $17.293 million (dollar_amount) — gross profit for Q3 2024
• $7.029 million (dollar_amount) — product liability claims for Q3 2025
• $1.442 million (dollar_amount) — transformation expenses for Q3 2025
• $182.250 million (dollar_amount) — long-term debt as of September 30, 2025

FAQ

Risk Factors

• Product Liability Claims [medium — legal]: The company incurred $7.029 million in product liability claims during Q3 2025, a new expense not present in the prior year's comparable period. This indicates potential ongoing legal challenges related to product safety or efficacy.
• Increased Leverage [medium — financial]: Long-term debt increased to $182.250 million as of September 30, 2025, up from $147.332 million at December 31, 2024. This represents a significant increase in financial leverage, potentially increasing financial risk.
• Transformation Project Costs [low — operational]: While transformation expenses decreased significantly to $1.442 million in Q3 2025 from $8.139 million in Q3 2024, the ongoing nature of digital and structural transformation projects suggests continued investment and potential for disruption.

Industry Context

The agricultural chemical industry is subject to seasonal demand and regulatory scrutiny. Companies like American Vanguard Corp operate in a competitive landscape, balancing innovation with compliance. Trends include a focus on sustainable agriculture and the development of more targeted crop protection solutions.

Regulatory Implications

The agricultural sector faces ongoing regulatory oversight regarding product safety, environmental impact, and efficacy. Changes in regulations or approval processes can significantly affect product portfolios and market access for companies like AVD.

What Investors Should Do

1. Monitor product liability developments.
2. Analyze the sustainability of gross margin improvement.
3. Evaluate the impact of increased debt.
4. Track the performance of U.S. Crop Sales.

Glossary

Condensed Consolidated Statements of Operations

A summary of a company's revenues, expenses, and profits over a specific period, presented in an unaudited format for interim financial reporting. (Provides the primary data for net sales, cost of sales, gross profit, and net loss for the reported periods.)

Condensed Consolidated Balance Sheets

A snapshot of a company's assets, liabilities, and equity at a specific point in time, presented in an unaudited format. (Shows the company's financial position, including its debt levels and equity, as of September 30, 2025.)

Condensed Consolidated Statements of Cash Flows

Reports the cash generated and used by a company during a specific period, categorized into operating, investing, and financing activities. (Helps understand the company's liquidity and how it is funding its operations and investments.)

Product Liability Claims

Costs incurred by a company due to lawsuits or settlements arising from damages caused by its products. (A new and significant expense for AVD in Q3 2025, impacting profitability.)

Transformation Expenses

Costs associated with significant changes to a company's business structure, operations, or digital infrastructure. (Indicates progress and investment in AVD's strategic initiatives, with a notable decrease in Q3 2025.)

Year-Over-Year Comparison

American Vanguard Corp (AVD) shows a mixed financial performance compared to the prior year. While net losses have narrowed significantly and gross profit has more than doubled due to a substantial reduction in cost of sales, net sales saw only a marginal increase in the quarter and a decrease year-to-date. The company has incurred new product liability claims and increased its long-term debt, indicating potential emerging risks and higher leverage, although transformation expenses have decreased substantially.

Filing Documents

• avd-20250930.htm (10-Q) — 2492KB
• avd-ex31_1.htm (EX-31.1) — 15KB
• avd-ex31_2.htm (EX-31.2) — 15KB
• avd-ex32_1.htm (EX-32.1) — 11KB
• 0001193125-25-273381.txt ( ) — 9156KB
• avd-20250930.xsd (EX-101.SCH) — 1065KB
• avd-20250930_htm.xml (XML) — 1697KB

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited) Condensed Consolidated Statements of Operations 3 Condensed Consolidated Statements of Comprehensive Loss 4 Condensed Consolidated Balance Sheets 5 Condensed Consolidated Statements of Stockholders' Equity 6 Condensed Consolidated Statements of Cash Flows 8 Notes to Condensed Consolidated Financial Statements 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 19 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 27 Item 4.

Controls and Procedures

Controls and Procedures 27

—OTHER INFORMATION

PART II—OTHER INFORMATION 29 Item 1.

Legal Proceedings

Legal Proceedings 29 Item 1A. Risks Factors 29 Item 2. Purchases of Equity Securities by the Issuer 29 Item 6. Exhibits 30

FINANCI AL INFORMATION

PART I. FINANCI AL INFORMATION

FINANC IAL STATEMENTS

Item 1. FINANC IAL STATEMENTS AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited) For the Three Months Ended September 30, For the Nine Months Ended September 30, 2025 2024 2025 2024 Net sales $ 119,313 $ 118,307 $ 364,426 $ 381,659 Cost of sales ( 85,099 ) ( 101,014 ) ( 259,474 ) ( 284,185 ) Gross profit 34,214 17,293 104,952 97,474 Operating expenses Selling, general and administrative ( 26,747 ) ( 26,365 ) ( 81,998 ) ( 86,885 ) Research, product development and regulatory ( 5,654 ) ( 11,177 ) ( 17,139 ) ( 25,482 ) Product liability claims ( 7,029 ) — ( 7,029 ) — Transformation ( 1,442 ) ( 8,139 ) ( 5,254 ) ( 16,636 ) Assets impairment ( 93 ) — ( 227 ) — Gain from sale of asset 246 — 246 — Operating loss ( 6,505 ) ( 28,388 ) ( 6,449 ) ( 31,529 ) Change in fair value of equity investment ( 511 ) — ( 511 ) 513 Interest expense, net ( 4,920 ) ( 4,378 ) ( 13,135 ) ( 11,988 ) Loss before provision for income taxes ( 11,936 ) ( 32,766 ) ( 20,095 ) ( 43,004 ) Income tax (expense) benefit ( 422 ) 7,024 ( 1,574 ) 7,093 Net loss $ ( 12,358 ) $ ( 25,742 ) $ ( 21,669 ) $ ( 35,911 ) Net loss per common share—basic $ ( 0.43 ) $ ( 0.91 ) $ ( 0.76 ) $ ( 1.28 ) Net loss per common share—assuming dilution $ ( 0.43 ) $ ( 0.91 ) $ ( 0.76 ) $ ( 1.28 ) Weighted average shares outstanding—basic 28,511 28,173 28,377 28,015 Weighted average shares outstanding—assuming dilution 28,511 28,173 28,377 28,015 See notes to the unaudited Condensed Consolidated Financial Statements. 3 AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEM E

View Full Filing

View this 10-Q filing on SEC EDGAR